Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Bryostatin Treatment of Moderately Severe Alzheimer's Disease

ClinicalTrials.gov ID: NCT04538066

Public ClinicalTrials.gov record NCT04538066. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 22, 2026, 4:17 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study Assessing Safety, Tolerability and Long-term Efficacy of Bryostatin in the Treatment of Moderately Severe Alzheimer's Disease Subjects Not Receiving Memantine Treatment

Study identification

NCT ID
NCT04538066
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Neurotrope Bioscience, Inc.
Industry
Enrollment
122 participants

Conditions and interventions

Interventions

  • Bryostatin 1 Drug
  • Placebo Other

Drug · Other

Eligibility (public fields only)

Age range
55 Years to 85 Years
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 29, 2020
Primary completion
Nov 15, 2022
Completion
Nov 15, 2022
Last update posted
Jul 30, 2024

2020 – 2022

United States locations

U.S. sites
19
U.S. states
9
U.S. cities
19
Facility City State ZIP Site status
Axiom Research Colton California 92324
Pacific Research Network San Diego California 92103
JEM Research Atlantis Florida 33462
Galiz Research Hialeah Florida 33016
ClinCloud Maitland Florida 32751
Miami Dade Medical Research Institute Miami Florida 33176
Anchor Neuroscience Pensacola Florida 32502
Progressive Medical Research Port Orange Florida 32127
Alzheimer's Research and Treatment Center Wellington Florida 33414
Atlanta Center for Medical Research Atlanta Georgia 30331
Columbus Memory Center Columbus Georgia 31909
iResearch Atlanta Decatur Georgia 30030
iResearch Savannah Savannah Georgia 31405
Fort Wayne Neurological Center Fort Wayne Indiana 46804
Millenium Psychiatric Associates St Louis Missouri 63132
Neurological Associates of Albany, P. C. Albany New York 12208
Alzheimer's Research Center Matthews North Carolina 28105
Summitt Research Network (Oregon) Portland Oregon 97210
Kingfisher Cooperative Spokane Washington 99202

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04538066, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 30, 2024 · Synced Apr 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04538066 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →